Catalyst Pharmaceutical CPRX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's operating cash flow?
- Catalyst Pharmaceutical (CPRX) reported operating cash flow of $59.59M in Q1 2026.
- How has Catalyst Pharmaceutical's operating cash flow changed year-over-year?
- Catalyst Pharmaceutical's operating cash flow decreased by 0.8% year-over-year, from $60.04M to $59.59M.
- What is the long-term trend for Catalyst Pharmaceutical's operating cash flow?
- Over 4 years (2021 to 2025), Catalyst Pharmaceutical's operating cash flow has grown at a 36.4% compound annual growth rate (CAGR), from $60.37M to $208.67M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.